Search Results

1 - 10 of 1,032 items :

  • "type 2 diabetes" x
Clear All
Somatotype characteristics of male patients with type 2 diabetes mellitus

, Putzu PF, et al. Somatotype in elderly type 2 diabetes patients. Coll Antropol 2007;31(3):733-7. 6. Vikram SY, Shyamal K, Sandhu JS, et al. A study on somatotyping of patients with type 2 diabetes mellitus in Amritsar. Kamla-Raj Anthropologist 2007;9(3):247-9. 7. Akabaliev V, Sivkov S, Nonchev P, Mantarkov M. Somatotype variability and cluster category in schizophrenics and healthy controls dependent on gender. Folia Psychiatrica 2011;2(3):68-75. 8. Toteva M. Somatotype characteristics of sportsmen. [PhD thesis

Open access
Selected health behaviours of type 2 diabetes patients

stan posiadanej wiedzy o chorobie u osób z rozpoznaniem cukrzycy typu 2. Diabetol Prakt. 2011;12(2):71-7. 9. Dudzińska M, Tarach JS, Malicka J, et al. Assessment of changes in self-control among patients with type 2 diabetes after the introduction of insulin therapy – a prospective study. Fam Med Primary Care Rev. 2013;15(3):315-7. 10. Włodarek D, Głąbska D. Zwyczaje żywieniowe osób chorych na cukrzycę typu 2. Diabetol Prakt. 2010;11(1):17-23. 11. Kurowska K, Frąckowiak M. Wsparcie społeczne a radzenie sobie w przewlekłej chorobie na przykładzie

Open access
Type 2 Diabetes and Hashimoto Thyroiditis-Possible Associations and Clinical Correlations - Preliminary Results

. Clustering of additional autoimmunity behaves differently in Hashimoto’s patients compared with Graves’ patients. Eur J Endocrinol 164(5): 789-94, 2011 7. Lawson E . Correlation between Diabetes Mellitus and Thyroid Dysfunction: Genetic Basis and Literature Rewiew. Advances in Bioscience & Clinical Medicine 4(2) 3-10, 2016. 8. Ravishankar SN, Champakamalini, Venkatesh, Mohsin . A perospective study of thyroid dysfunction in patients with Type 2 diabetes in general population. iMedPub Journals 5(12), 2013 9. McConahey WM, Keating FR Jr, Beahrs OH

Open access
Serum leptin concentration in patients with type 2 diabetes

L.Q., Ye J.K.: Leptin levels and risk of type 2 diabetes: gender-specific meta-analysis. Obes. Rev., 15(2), 134, 2014. 5. Chen K. et. al.: Induction of leptin resistance through direct interaction of C-reactive protein with leptin. Nat. Med., 12(4), 425, 2006. 6. Correia M.L., Rahmouni K.: Role of leptin in the cardiovascular and endocrine complications of metabolic syndrome. Diabetes Obes. Metab., 8(6), 603, 2006. 7. Dardeno T.A. et. al.: Leptin in human physiology and therapeutics. Front Neuroendocrinol., 31

Open access
Removable Dentures Treatment Satisfaction of Patients with Type-2 Diabetes

R eferences 1. Renard LM, Bocquet V, Vidal-Trecan G et al. Adherence to international follow-up guidelines in type 2 diabetes: a longitudinal cohort study in Luxembourg. PLoS One 8(11):11, 2013. 2. Sandberg GE, Sundberg HE, Fjellstrom CA, et.al. Type 2 diabetes and oral health: a comparison between diabetic and non-diabetic subjects. Diabetes Res Clin Pract 50(1): 27-34, 2000. 3. Yamaga E, Sato Y, Minakuchi S. A structural equation model relating oral condition, denture quality, chewing ability, satisfaction, and oral health

Open access
Type 2 Diabetes and its Implications in Cerebrovascular Disease

population study of 3.3 million people. Circulation 117(15): 1945-1954, 2008. Sander D, Etgen T, Poppert H, Sander K. Reducing the Risk of Stroke in Type 2 Diabetes: A Critical Review. The European Neurological Journal 2(2), 2010. Avogaro A, Albiero M, Menegazzo L, Kreutzenberg S, Fadin. Endothelial Dysfunction in Diabetes. The role of reparatory mechanisms. Diabetes Care 34(Supplement 2): S285-S290, 2011. Zoungas S, Chalmers J, Ninomiya T, Li Q, Cooper M E, Colagiuri S, Fulcher G, B. E

Open access
Insulin Initiation in Type 2 Diabetes – Why, When and How?

R eferences 1. Festa A, Williams K, D’Agostino R Jr, Wagenknecht LE, Haffner SM. The natural course of beta-cell function in nondiabetic and diabetic individuals: the Insulin Resistance Atherosclerosis Study. Diabetes 55: 1114-1120, 2006. 2. Funakoshi S, Fujimoto S, Hamasaki A et al. Analysis of factors influencing pancreatic beta-cell function in Japanese patients with type 2 diabetes: association with body mass index and duration of diabetic exposure. Diabetes Res Clin Pract 82: 353-358, 2008. 3. Saydah SH, Fradkin J, Cowie CC. Poor

Open access
Malnutrition and Metabolic Changes in Patients with Type 2 Diabetes

Malnutrition in Patients with Diabetes Mellitus: A Sub-Analysis of the PREDyCES® Study. SM J Public Health Epidemiol . 2015;1:1018. 4. Norman K, Pichard C, Lochs H, Pirlich M. Prognostic impact of disease related malnutrition. Clin Nutr . 2008;27:5-15. 5. Haydock DA, Hill GL. Impaired wound healing in surgical patients with varying degrees of malnutrition. JPEN J Parenter Enteral Nutr . 1986;10:550-554. 6. Liu GX, Chen Y, Yang YX, et al. Pilot study of the Mini Nutritional Assessment on predicting outcomes in older adults with type 2 diabetes. Geriatr

Open access
Heart Failure and Chronic Kidney Disease in Type 2 Diabetes

Diabetes Atlas, 2015. Available at: http://www.diabetesatlas.org 5. Thomas MC, Cooper ME, Zimmet P. Changing epidemiology of type 2 diabetes mellitus and associated chronic kidney disease. Nat Rev Nephrol . 2016;12:73-81. 6. Roberts AW, Clark AL, Witte KK. Review article: Left ventricular dysfunction and heart failure in metabolic syndrome and diabetes without overt coronary artery disease — do we need to screen our patients? Diab Vasc Dis Res . 2009;6:153-163. 7. Boonman-de Winter LJ, Rutten FH, Cramer MJ, et al. High prevalence of previously

Open access
Diabetic nephropathy in type 2 diabetes – from pathological mechanisms to clinical occupational medicine practice

27. He F, Xia X, Wu XF, Yu XQ, Huang FX. Diabetic retinopathy in predicting diabetic nephropathy in patients with type 2 diabetes and renal disease: a meta-analysis. Diabetologia 2013;56:457–66. 28. Uwaezuoke SN.The role of novel biomarkers in predicting diabetic nephropathy: a review. Int J Nephrol Renovasc Dis 2017:10: 221-31. 29. Li Y, Xia W, Zhao F, Wen Z, Zhang A, Huang S, Jia Z, Zhang Y. Prostaglandins in the pathogenesis of kidney diseases. Oncotarget. 2018;9:26586–26602. 30. Al-Rubeaan K, Siddiqui K, Al-Ghonaim MA, Youssef AM, Al

Open access